APIS CAPITAL ADVISORS, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 88 filers reported holding ENZO BIOCHEM INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
APIS CAPITAL ADVISORS, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2015$358,000
+53.6%
113,000
+46.8%
0.50%
+88.9%
Q2 2015$233,000
+75.2%
77,000
-3.8%
0.26%
+44.0%
Q1 2015$133,000
-60.1%
80,000
+6.7%
0.18%
-50.8%
Q4 2014$333,00075,0000.37%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders